• Thumbnail for Rofecoxib
    Rofecoxib is a COX-2-selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis...
    76 KB (8,141 words) - 20:25, 3 August 2024
  • reduces the risk of peptic ulceration and is the main feature of celecoxib, rofecoxib, and other members of this drug class. After several COX-2–inhibiting...
    42 KB (4,944 words) - 11:56, 4 April 2024
  • became the building-block for synthesis of COX-2 inhibitors. Celecoxib and rofecoxib, the first COX-2 inhibitors to reach market, were based on DuP-697. It...
    37 KB (4,463 words) - 13:48, 4 June 2023
  • Thumbnail for Etoricoxib
    complicated upper gastrointestinal events are similar between two groups. Like rofecoxib's VIGOR trial, the MEDAL Program was also criticized, this time due to...
    13 KB (1,155 words) - 14:50, 7 September 2024
  • Thumbnail for Nonsteroidal anti-inflammatory drug
    heart attack. As a result, certain COX-2 selective inhibitors—such as rofecoxib—are no longer used due to the high risk of undiagnosed vascular disease...
    111 KB (11,585 words) - 12:08, 31 October 2024
  • Thumbnail for Analgesic
    (traditional NSAIDs block both versions in general). These drugs (such as rofecoxib, celecoxib, and etoricoxib) are equally effective analgesics when compared...
    109 KB (5,859 words) - 00:50, 28 October 2024
  • Thumbnail for Celecoxib
    advice to physicians regarding celecoxib's safety. The COX-2 inhibitor rofecoxib (Vioxx) was removed from the market in 2004 due to its risk. Like all...
    61 KB (6,086 words) - 21:24, 28 September 2024
  • Thumbnail for Grapiprant
    the dosage and its effects are comparable to human medications such as rofecoxib and piroxicam. Grapiprant has also been tested in humans, and was researched to...
    11 KB (1,033 words) - 21:58, 15 September 2024
  • Thumbnail for Diclofenac
    of increased risks of heart attacks with the selective COX-2 inhibitor rofecoxib in 2004, attention has focused on all the other members of the nonsteroidal...
    56 KB (5,251 words) - 06:17, 13 October 2024
  • Thumbnail for Nimesulide
    double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee". Drugs. 63 (Suppl 1): 37–46. doi:10...
    19 KB (1,789 words) - 20:47, 17 September 2024
  • Thumbnail for Ketamine
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    116 KB (11,202 words) - 07:03, 1 November 2024
  • Thumbnail for Cannabis (drug)
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    165 KB (17,237 words) - 23:10, 27 October 2024
  • Ramelteon Rasagiline Reboxetine Ribavirin Rimonabant Risperidone Rivastigmine Rofecoxib Ropinirole Rotigotine Rufinamide Selegiline Sertraline Sevoflurane Sulpiride...
    26 KB (1,722 words) - 21:40, 3 October 2024
  • Thumbnail for Naproxen
    Tanaka W, et al. (October 2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1...
    38 KB (3,585 words) - 09:02, 29 October 2024
  • A.; et al. (2000). "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis". New England Journal...
    35 KB (3,648 words) - 06:45, 6 October 2024
  • Thumbnail for Eric Topol
    one of the first researchers to question the cardiovascular safety of rofecoxib (Vioxx), culminating in that drug's withdrawal from the market. Topol's...
    28 KB (3,089 words) - 09:58, 27 October 2024
  • Thumbnail for Cyclooxygenase
    thromboxane unbalanced by prostacyclin (which is reduced by COX-2 inhibition). Rofecoxib (brand name Vioxx) was withdrawn in 2004 because of such concerns. Some...
    16 KB (1,779 words) - 11:08, 3 July 2024
  • Thumbnail for Fentanyl
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    174 KB (16,179 words) - 22:49, 30 October 2024
  • Thumbnail for Osteoarthritis
    effective for a small number of people. The COX-2 selective inhibitor rofecoxib was removed from the market in 2004, as cardiovascular events were associated...
    131 KB (13,644 words) - 23:06, 28 October 2024
  • Thumbnail for Alcohol (drug)
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    256 KB (26,705 words) - 22:28, 1 November 2024
  • Thumbnail for Morphine
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    141 KB (13,802 words) - 13:41, 27 October 2024
  • Thumbnail for Rheumatoid arthritis
    caution in those with gastrointestinal, cardiovascular, or kidney problems. Rofecoxib was withdrawn from the global market as its long-term use was associated...
    148 KB (16,082 words) - 23:08, 18 October 2024
  • Thumbnail for Heroin
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    116 KB (11,944 words) - 17:09, 1 November 2024
  • Thumbnail for Paracetamol
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    122 KB (12,155 words) - 00:35, 29 October 2024
  • Thumbnail for Food and Drug Administration
    Horgan K, et al. (March 2005). "Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial". The New England Journal...
    121 KB (12,011 words) - 19:53, 11 October 2024
  • cerivastatin (brand names Baycol and Lipobay), troglitazone (Rezulin) and rofecoxib (Vioxx).[citation needed] The entire process of developing a drug from...
    32 KB (3,829 words) - 15:51, 28 June 2024
  • indomethacin, the use of celecoxib 400–800 mg per day (Celebrex) and rofecoxib 50 mg per day (Vioxx - no longer available) have both been shown to be...
    13 KB (1,500 words) - 21:49, 27 July 2024
  • Thumbnail for Etodolac
    COX-2 selective similar to celecoxib and other "COX-2 inhibitors." Unlike rofecoxib, both etodolac and celecoxib can fully inhibit COX-1 and are designated...
    10 KB (870 words) - 22:39, 9 August 2024
  • Thumbnail for Nitrous oxide
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    95 KB (9,781 words) - 14:36, 30 October 2024
  • Thumbnail for Ketorolac
    COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic acid Meclofenamic acid Mefenamic acid...
    31 KB (2,646 words) - 00:18, 26 October 2024